Brief: Schott Pharma Reaffirms FY 2025 Guidance
May 15 (Reuters) - SCHOTT Pharma AG & Co KgaA 1SXP.DE: REAFFIRMS FY 2025 GUIDANCE ON US TARIFFS: DIRECT IMPACT IS EXPECTED TO BE LIMITED Source text: ID:nEQc2dTfGa Further company coverage: 1SXP.DE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on SCHOTT Pharma AG & Co. KGaA
See all newsEurope Research Roundup: GSK, Schott Pharma, Vodafone
SCHOTT Pharma rises after J.P. Morgan initiates with 'Overweight'
Schott Pharma rises after Barclays upgrades to 'overweight' on accelerating growth outlook
Europe Research Roundup: Adyen, GYM Group, Rolls Royce
Brief: Schott Pharma - Confirms Recently Increased 2026 Financial Year Guidance